R&D Systems™ Recombinant Human LILRB5/CD85c/LIR-8 Fc Chimera Protein

Description

Measured by its binding ability in a functional ELISA.

Measured by its binding ability in a functional ELISA. When Recombinant Human LILRB5/CD85c/LIR-8 Fc Chimera (Catalog # 10410-T4) is immobilized at 0.5 μg/mL (100 μL/well), Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (Catalog # 914-AN ) binds with an ED50 of 0.03-0.24 μg/mL.

Specifications

• Accession Number: O75023.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 10990
• Molecular Weight (g/mol): M.W. (Observed): 85-105 kDa, under reducing conditions; M.W. (theoretical): 74 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human LILRB5/CD85c/LIR-8 protein Human LILRB5/CD85c/LIR-8 (Gly24-Gly458) (N-terminus) Accession # O75023.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: LIR-8/CD85c/LILRB5